Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-alpha for Molecular Relapse in t(8;21) AML After Allo-HSCT
NCT02027064Phase 4Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2013
- Primary completion
- Oct 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of interferon alfa in acute myeloid leukemia (AML), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
interferon alfa
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02027064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027064.